Skip to main content

War of words begins over Versum offer

4th March 2019

Submitted by:

Andrew Warmington

Merck KGaA has published an open letter to the shareholders of electronic chemicals producer Versum Materials after its board rejected an unsolicited offer to buy the company. Versum, which was spun off from Air Products & Chemicals in 2016, is in the process of a merger with Entegris and wishes to continue pursuing this. Merck made its offer of $48/share, giving Versum an enterprise value of about $5.9 billion, on 27 February.

Merck chairman and CEO Stefan Oschmann said that a combination “would create a deep and complementary portfolio of electronic materials, equipment and services for the semiconductor and display industries”. However, Versum responded that, “after careful review and consideration”, it had concluded that Merck’s “is not a superior proposal” and that the merger with Entegris “will create significant long-term value and is in the best interest of Versum’s shareholders”. Entegris CEO Bertrand Loy called its proposed deal “highly complementary and strategically compelling”.

The planned merger with Massachusetts-based Entegris, creating a global speciality materials player with an enterprise value of $9 billion, was unveiled in January. This is due to be completed in 2H 2019; Merck said that it was confident it could close a transaction with Versum in the same timeframe if the Versum board engages with it.

In its letter, Merck said that it was “disappointed” that the Versum board “has rejected without explanation our superior proposal” or accept “our offer to engage directly with Versum to understand the rationale for [this decision]”. It noted that the offer is a 51.7% premium to Versum’s pre-announcement price and 17.1% on the value of the Entegris stock they were being offered.

In addition, Merck said, its offer is “certain and immediate, without any of the significant ongoing integration, operational or market risks reflected in the value of the Entegris stock consideration and without the need for the achievement of synergies”. Versum’s own financial advisor, Lazard, had also concluded that the Merck offer was superior, it said.

The company added that it “has a strong reputation for innovation and has demonstrated a robust commitment to R&D spending and capital investment”. This philosophy, it said “is consistent with Versum’s culture and strength of its employees”. It would maintain Versum’s site at Tempe, Arizona, as its main hub for the combined electronic materials business in the US. News agency Bloomberg has indicated that Merck had been looking to buy Versum ever since the spin-off but was blindsided by Entegris. If it were to acquire Versum, semiconductors, which currently account for less than 20% of sales, would be about half of them. 

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Axplora's site at Vizag

Axplora expands in India

Axplora has announced a “significant” investment at its site in Vizag, India (pictured)

Submitted by:

Andrew Warmington

Regis' headquarters in Chicago

Esteve acquires Regis

 

Barcelona-based Esteve Química has acquired Regis Technologies, a hitherto privately owned CDMO headquartered in Chicago

Submitted by:

Andrew Warmington

Meribel's facility at Uppsala

Ofichem buys site in Sweden

Netherlands-based CDMO Ofichem has acquired Meribel Pharma Solutions’ former Recipharm site in Uppsala, Sweden, which

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington